Bedford, MA-based Hologic said on Friday it has received approval from the U.S. Food and Drug Administration for its 3-D imaging system for doing breast cancer screening and diagnosis. The company’s X-ray mammography device, called the Selenia Dimensions System, is the first of its kind to provide 3-D images of the breast, according to the FDA. Radiologists in two studies showed a 7 percent improvement in their ability to distinguish between cancerous and non-cancerous cases when they viewed both 3-D and conventional 2-D images, as compared to 2-D images alone. The idea is that Hologic’s 3-D imaging technology can supplement, not replace, conventional breast scanning. The company’s imaging system is already available in more than 40 countries, including Canada and Mexico.
Author: Gregory T. Huang
Greg is a veteran journalist who has covered a wide range of science, technology, and business. As former editor in chief, he overaw daily news, features, and events across Xconomy's national network. Before joining Xconomy, he was a features editor at New Scientist magazine, where he edited and wrote articles on physics, technology, and neuroscience. Previously he was senior writer at Technology Review, where he reported on emerging technologies, R&D, and advances in computing, robotics, and applied physics. His writing has also appeared in Wired, Nature, and The Atlantic Monthly’s website. He was named a New York Times professional fellow in 2003.
Greg is the co-author of Guanxi (Simon & Schuster, 2006), about Microsoft in China and the global competition for talent and technology. Before becoming a journalist, he did research at MIT’s Artificial Intelligence Lab. He has published 20 papers in scientific journals and conferences and spoken on innovation at Adobe, Amazon, eBay, Google, HP, Microsoft, Yahoo, and other organizations. He has a Master’s and Ph.D. in electrical engineering and computer science from MIT, and a B.S. in electrical engineering from the University of Illinois, Urbana-Champaign.
View all posts by Gregory T. Huang